Bruker (BRKR) Debt to Equity (2010 - 2026)
Bruker posted quarterly Debt to Equity of $0.68 for Q1 2026, down 41.26% year-on-year from $1.15 in Q1 2025, and down 10.35% on a QoQ basis from $0.76 in Q4 2025.
Bruker (BRKR) has 17 years of Debt to Equity data on file, last reported at $0.68 in Q1 2026.
- For the quarter ending Q1 2026, Debt to Equity fell 41.26% year-over-year to $0.68; the trailing twelve-month figure through Mar 2026 stood at $0.68 (down 41.26% YoY), and the FY2025 full-year result was $0.76, down 34.3% from the prior year.
- Debt to Equity for Q1 2026 stood at $0.68, down from $0.76 in the prior quarter.
- Across five years, Debt to Equity topped out at $1.34 in Q2 2025 and bottomed at $0.68 in Q1 2026.
- The 5-year median for Debt to Equity is $1.07 (2022), against an average of $1.05.
- The widest annual swing landed in 2022, when Debt to Equity surged 60.36%; it then sank 41.26% in 2026.
- A 5-year view of Debt to Equity shows it stood at $1.07 in 2022, then fell by 14.41% to $0.92 in 2023, then advanced by 25.16% to $1.15 in 2024, then plunged by 34.3% to $0.76 in 2025, then dropped by 10.35% to $0.68 in 2026.
- The last three Debt to Equity figures came in at $0.68 (Q1 2026), $0.76 (Q4 2025), and $0.83 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.65 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.64 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.57 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.42 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.06 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.95 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.27 |
| 10 | Bruker | 8.89 Bn | 8.77 Bn | 379.80 Mn | 0.68 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.68 |
| Dec 31, 2025 | 0.76 |
| Sep 30, 2025 | 0.83 |
| Jun 30, 2025 | 1.34 |
| Mar 31, 2025 | 1.15 |
| Dec 31, 2024 | 1.15 |
| Sep 30, 2024 | 1.26 |
| Jun 30, 2024 | 1.19 |
| Mar 31, 2024 | 0.96 |
| Dec 31, 2023 | 0.92 |
| Sep 30, 2023 | 0.99 |
| Jun 30, 2023 | 0.99 |
| Mar 31, 2023 | 1.03 |
| Dec 31, 2022 | 1.07 |
| Sep 30, 2022 | 1.22 |
| Jun 30, 2022 | 1.20 |
| Mar 31, 2022 | 1.18 |
| Dec 31, 2021 | 1.13 |
| Sep 30, 2021 | 0.76 |
| Jun 30, 2021 | 0.82 |
| Mar 31, 2021 | 0.84 |
| Dec 31, 2020 | 0.87 |
| Sep 30, 2020 | 0.86 |
| Jun 30, 2020 | 1.13 |
| Mar 31, 2020 | 1.09 |
| Dec 31, 2019 | 0.89 |
| Sep 30, 2019 | 0.61 |
| Jun 30, 2019 | 0.57 |
| Mar 31, 2019 | 0.36 |
| Dec 31, 2018 | 0.38 |
| Sep 30, 2018 | 0.29 |
| Jun 30, 2018 | 0.28 |
| Mar 31, 2018 | 0.28 |
| Dec 31, 2017 | 0.58 |
| Sep 30, 2017 | 0.65 |
| Jun 30, 2017 | 0.56 |
| Mar 31, 2017 | 0.53 |
| Dec 31, 2016 | 0.58 |
| Sep 30, 2016 | 0.52 |
| Jun 30, 2016 | 0.52 |
| Mar 31, 2016 | 0.43 |
| Dec 31, 2015 | 0.36 |
| Sep 30, 2015 | 0.49 |
| Jun 30, 2015 | 0.48 |
| Mar 31, 2015 | 0.50 |
| Dec 31, 2014 | 0.47 |
| Sep 30, 2014 | 0.44 |
| Jun 30, 2014 | 0.40 |
| Mar 31, 2014 | 0.41 |
| Dec 31, 2013 | 0.42 |
| Sep 30, 2013 | 0.46 |
| Jun 30, 2013 | 0.47 |
| Mar 31, 2013 | 0.49 |
| Dec 31, 2012 | 0.48 |
| Sep 30, 2012 | 0.49 |
| Jun 30, 2012 | 0.50 |
| Mar 31, 2012 | 0.49 |
| Dec 31, 2011 | 0.49 |
| Sep 30, 2011 | 0.43 |
| Jun 30, 2011 | 0.39 |
| Mar 31, 2011 | 0.19 |
| Dec 31, 2010 | 0.52 |